stockrowArtivion, Inc. (AORT) vs Integra LifeSciences Holdings Corporation (IART)
- Artivion, Inc. AORT 20.27 −19.98%
- Integra LifeSciences Holdings Corporation IART 13.41 −5.03%
Artivion, Inc. and Integra LifeSciences Holdings Corporation are both Medical Devices companies. Artivion, Inc. is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Artivion, Inc. has negative trailing earnings, so its P/E is not meaningful; Integra LifeSciences Holdings Corporation trades at 78.9×. Artivion, Inc. grew revenue faster over the last twelve months: 14.0% against 0.84%. Integra LifeSciences Holdings Corporation has the higher net margin (0.79% vs 0.00%) and the higher return on invested capital (1.79% vs 0.90%). Across the 19 metrics below, Integra LifeSciences Holdings Corporation leads on 13 and Artivion, Inc. on 6.
Valuation
Profitability
| Metric | AORT | IART | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.31% | 52.36% | 57.76% |
| Operating margin | 2.29% | 4.39% | (14.84%) |
| Net margin | 0.00% | 0.79% | (14.45%) |
| Free cash flow margin | (9.21%) | 5.18% | (5.70%) |
| Return on equity | 0.00% | 1.24% | (10.56%) |
| Return on assets | 0.00% | 0.36% | (17.26%) |
| Return on invested capital | 0.90% | 1.79% | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack